Pharma firm Jubilant Organosys on Tuesday said it has joined hands with the University of Alabama at Birmingham and Southern Research Institute to benefit from their collective innovation and enabling technologies.

"We are happy to join hands with UAB and Southern Research Institute, known for its strengths in the areas of oncology, metabolic disease and infectious diseases," Jubilant Organosys Chairman and Managing Director S Bhartia said in a filing to the Bombay Stock Exchange.